<DOC>
	<DOCNO>NCT02454881</DOCNO>
	<brief_summary>To study multimodal protocol combine adjunct dexmedetomidine oxycodone intravenous patient-controlled analgesia bolus dose effect patient scheduled posterolateral lumbar spine fusion bilateral transpedicular screw instrumentation .</brief_summary>
	<brief_title>Dose Response Study Dexmedetomidine Orthopaedic Spine Surgery Patients</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>Scheduled elective posterolateral lumbar spine fusion bilateral transpedicular screw instrumentation general anaesthesia . Written informed consent participate subject A previous history intolerance study drug relate compound additive Concomitant drug therapy oxycodone buprenorphine . History ischemic heart disease conduction disturbance BMI &gt; 35 Existing significant haematological , endocrine , metabolic gastrointestinal disease History alcoholism , drug abuse , psychological emotional problem likely invalidate inform consent Allergy dexmedetomidine oxycodone Blood loss exceed 1500 ml operation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>